Press release
mRNA Cancer Vaccines And Therapeutics Market Size Forecasted To Achieve $131.99 Billion By 2029 With Steady Growth
mRNA Cancer Vaccines And Therapeutics
What Is the mRNA Cancer Vaccines And Therapeutics Market Size and Projected Growth Rate?
The mRNA cancer vaccines and therapeutics market has experienced rapid expansion. It will grow from $61.52 billion in 2024 to $71.85 billion in 2025 at a CAGR of 16.8%. This growth has been supported by evolving lifestyles, increased funding, a favorable regulatory environment, advanced healthcare systems, and a growing development pipeline.
The mRNA cancer vaccines and therapeutics market is forecast to experience rapid growth, expected to reach $131.99 billion by 2029, with a CAGR of 16.4%. The growth can be attributed to promising clinical trial results, increasing acceptance of mRNA technology, unmet needs in cancer treatment, potential for improved patient outcomes, and the possibility of off-the-shelf availability. Trends include expansion into new therapeutic areas, personalized medicine approaches, advances in mRNA delivery systems, multivalent vaccines, and the use of AI and ML in mRNA design.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17204
What Are the Major Segments in the mRNA Cancer Vaccines And Therapeutics Market?
The mRNA cancer vaccines and therapeutics market covered in this report is segmented -
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp
What Are The Driving mRNA Cancer Vaccines And Therapeutics Market Evolution?
In the healthcare sector, the mRNA cancer vaccine and therapeutics market is benefiting from the rising prevalence of cancer. As cancer rates continue to climb globally, innovative treatments like mRNA vaccines are proving effective in offering more personalized and targeted approaches. This market is likely to experience significant growth, particularly in light of new advancements in mRNA technology, which has shown promise in providing more effective, faster treatments for various types of cancer.
Which Firms Dominate The mRNA Cancer Vaccines And Therapeutics Market Segments?
Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
What Trends Are Expected to Dominate the mRNA Cancer Vaccines And Therapeutics Market in the Next 5 Years?
Major players in the mRNA cancer vaccine and therapeutics market are developing cutting-edge mRNA vaccines to improve treatment outcomes. In May 2024, WestGene Biopharma received FDA approval for WGc-043, an mRNA cancer vaccine for treating advanced EB virus-related cancers.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report
Which Is The Largest Region In The mRNA Cancer Vaccines And Therapeutics Market?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the mRNA Cancer Vaccines And Therapeutics Market?
2. What is the CAGR expected in the mRNA Cancer Vaccines And Therapeutics Market?
3. What Are the Key Innovations Transforming the mRNA Cancer Vaccines And Therapeutics Industry?
4. Which Region Is Leading the mRNA Cancer Vaccines And Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Cancer Vaccines And Therapeutics Market Size Forecasted To Achieve $131.99 Billion By 2029 With Steady Growth here
News-ID: 4041959 • Views: …
More Releases from The Business Research Company
2025-2034 Mainframe Modernization Market Evolution: Emerging Opportunities and M …
What Is the Projected Size of the Mainframe Modernization Market by 2025?
Recent years have witnessed substantial expansion in the market dedicated to mainframe modernization, with projections indicating a climb from a valuation of $15.72 billion in 2024 up to $18.12 billion by 2025, a trajectory translating to a compound annual growth rate (CAGR) of 15.2%. This historical upward trend is fueled by several key factors, chief among them being escalating…
Accelerated Digital Transformation Fuels Expansion in the Liquid Crystal Polymer …
How Much Will the Liquid Crystal Polymer (LCP)-Based Molded Interconnect Device Market Size Increase by 2025?
The market for liquid crystal polymer (LCP)-based molded interconnect devices has experienced swift augmentation recently, projected to escalate from a value of $0.64 billion in 2024 to $0.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.3%. This historical expansion is largely traceable to several key factors, including the wider acceptance of…
Consistent Growth Projected for Land-Based Command, Control, Communications, Com …
How Much Is the Land-Based Command, Control, Communications, Computers, Intelligence, Surveillance, And Reconnaissance( C4ISR ) Market Expected to Expand by 2025?
The terrestrial C4ISR sector has experienced robust expansion lately, projected to increase its valuation from $32.64 billion in 2024 to $34.87 billion the following year, reflecting a steady compound annual growth rate of 6.8%. This upward trajectory in the past phase is traceable to several key factors, including a more…
Surging Application Across End Users Powers the Expansion of the Intelligent Ele …
How Large Is the Intelligent Electrical Panel Market Expected to Be by 2025?
The electrical panel segment characterized by intelligence has experienced swift expansion recently, projected to escalate its valuation from a total of $4.47 billion in the year 2024 to $4.95 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%; this upward trajectory throughout the preceding period is linked to several factors, namely the escalating need for…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
